S&P 500
7,541.40
-38.67
-0.51%
Dow
51,983.98
+213.67
+0.41%
Nasdaq
25,164.32
-272.68
-1.07%
NYSE Composite
24,372.07
+78.98
+0.33%
Russell 2000
2,805.88
-5.97
-0.21%
VIX
21.15
+1.73
+8.91%
DNA · Ginkgo Bioworks Holdings, Inc.
NEW YORK STOCK EXCHANGE, INC. - Real Time Price • USD
Ginkgo Bioworks Holdings, Inc. (DNA)
NEW YORK STOCK EXCHANGE, INC.
Life Sciences Tools & Services
$9.84
-1.39
(-12.42%)
● At close: November 2 at 4:00:00 PM EDT
$9.85
+0.00
(+0.00%)
After-Hours:
4:20:00 PM EDT
DAY'S RANGE
$9.84
$9.28
$11.10
52-WEEK RANGE
$9.84
$5.37
$18.22
What's happening
- DNA is down 12.42% today, trading at $9.84. — Live quote
- Volume today (167,177) is well below its 3-month average of 1,877,670. (Finnhub fundamentals)
- Reports earnings on 2026-11-05, 3 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $-0.75 actual vs. $-0.92 estimated (+18.4%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 0
Buy 0
Hold 3
Sell 4
Strong sell 3
Aggregate ratings for 2026-11-01 (10 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
DNA
+34.90%
vs S&P 500
+24.08%
1-YEAR RETURN
DNA
-6.66%
vs S&P 500
-17.82%
6-MONTH RETURN
DNA
+42.80%
3-MONTH RETURN
DNA
+38.57%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.75
Est. $-0.92
BEAT +18.4%
2026-04-26 (Q1 2026)
$-1.39
Est. $-1.09
MISS -27.4%
2026-01-26 (Q4 2025)
$-1.41
Est. $-1.47
BEAT +4.1%
2025-10-26 (Q3 2025)
$-1.45
Est. $-1.25
MISS -15.8%
Valuation Measures & Ratios
Enterprise Value4$670.3M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)6.75
Price / Book71.47
EV4 / Revenue5.99
EV4 / EBITDA—
Profit Margin-259.96%
Operating Margin-272.83%
Return on Equity (ROE8)-60.21%
Return on Assets (ROA9)-26.85%
Avg Volume (3M)1,877,670
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | — | — | $813.1M | $617.8M | $308.6M |
| P/E | — | — | -2.82 | -1.45 | — |
| Price/Sales | — | — | 3.96 | 2.78 | 1.39 |
| Price/Book | — | — | 1.45 | 1.01 | 0.48 |
| EV/Revenue | — | — | 3.42 | 1.86 | -0.02 |
| ROE | — | — | -51.52% | -69.31% | — |
| ROA | — | — | -24.25% | -34.51% | — |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short8,294,322
Change from Prior Settlement+13.38%
% of Float—
Days to Cover (Short Ratio)1.88
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-10-15. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 8-K, filed 2026-10-29; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -59.4% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is -260.0%. Finnhub fundamentals ↗
- Trailing 52-week price return is -6.7%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on DNA
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $20.2M | $19.5M | $38.8M | $39.1M | $38.2M | $89.0M | $56.2M | $37.9M |
| Operating income | -$58.5M | -$71.4M | -$90.0M | -$58.2M | -$81.0M | -$55.2M | -$222.9M | -$178.0M |
| Net income | -$46.7M | -$82.6M | -$80.8M | -$60.3M | -$91.0M | -$56.4M | -$217.2M | — |
| EPS (diluted) | — | — | $-1.45 | $-1.10 | $-1.68 | $-1.08 | $-4.23 | $-3.32 |
| EPS (basic) | $-0.75 | $-1.39 | $-1.45 | $-1.10 | $-1.68 | $-1.08 | $-4.23 | $-3.31 |
| Operating margin | -$290 | -$367 | -$232 | -$149 | -$212 | -$62 | -$397 | -$469 |
| Net margin | -$232 | -$424 | -$208 | -$154 | -$238 | -$63 | -$386 | — |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $990.0M | $1.03B | $1.12B | $1.19B | $1.23B | $1.29B | $1.38B | $1.48B |
| Total liabilities | $569.8M | $589.9M | $611.1M | $629.4M | $618.1M | $646.0M | $661.4M | $682.9M |
| Stockholders' equity | $420.3M | $443.2M | $508.6M | $559.8M | $613.0M | $647.4M | $716.1M | $797.9M |
| Total current assets | $332.5M | $410.0M | $471.8M | $506.1M | $523.0M | $564.5M | $602.7M | $662.5M |
| Total current liabilities | $72.7M | $79.6M | $96.0M | $115.3M | $96.7M | $115.7M | $107.3M | $114.4M |
| Cash & equivalents | $84.5M | $143.9M | $167.2M | $111.1M | $203.6M | $312.4M | $561.6M | $616.2M |
| Marketable securities (current) | — | — | $255.4M | $384.4M | $355.8M | $12.8M | $0 | — |
| Accounts receivable | $13.0M | $19.8M | $24.0M | $21.4M | $22.2M | $26.3M | $21.9M | $23.4M |
| Inventory | — | — | — | — | — | — | — | — |
| Other current assets | — | — | — | — | — | — | — | — |
| Property, plant & equipment | $157.2M | $163.0M | $167.4M | $176.6M | $186.4M | $197.8M | $203.7M | $211.0M |
| Goodwill | — | — | — | — | — | — | $0 | $0 |
| Intangible assets | $44.4M | $48.9M | $53.5M | $61.5M | $66.2M | $68.8M | $72.5M | $79.6M |
| Other non-current assets | $1.3M | $39.5M | $9.0M | $46.6M | $47.0M | $46.8M | $55.3M | $59.8M |
| Accounts payable | $9.6M | $16.3M | $10.6M | $10.7M | $11.2M | $11.3M | $14.2M | $15.7M |
| Accrued liabilities | — | — | — | — | — | — | — | — |
| Deferred revenue (current) | $13.2M | $14.9M | $18.9M | $25.2M | $28.3M | $33.7M | $27.7M | $22.9M |
| Other non-current liabilities | $16.4M | $21.7M | $22.9M | $17.2M | $17.9M | $15.4M | $16.6M | $17.7M |
| Common stock & paid-in capital | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K |
| Retained earnings | -$6.28B | -$6.23B | -$6.15B | -$6.07B | -$5.99B | -$5.93B | -$5.84B | -$5.73B |
| Accumulated other comprehensive income (loss) | $950.0K | $1.2M | $1.9M | $2.0M | $1.7M | -$850.0K | -$1.8M | $263.0K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$44.3M | -$46.7M | -$47.7M | -$31.6M | -$40.3M | -$51.5M | -$42.4M | -$103.5M |
| Investing cash flow | $11.1M | $23.1M | $95.1M | -$72.8M | -$63.9M | -$198.7M | -$13.1M | -$10.2M |
| Financing cash flow | $16.5M | -$19.0K | $8.1M | $9.9M | -$98.0K | -$207.0K | -$203.0K | -$465.0K |
| Free cash flow | -$46.9M | -$48.6M | -$47.7M | -$31.6M | -$40.3M | -$59.1M | -$56.1M | -$118.6M |
| Capital expenditures | $2.6M | $1.9M | $5.0K | $0 | $38.0K | $7.6M | $13.7M | $15.1M |
| Share-based compensation | $7.6M | $15.9M | $21.0M | $24.3M | $18.8M | $17.4M | $20.6M | $13.9M |
| Deferred income taxes | — | — | -$1.4M | — | — | — | -$936.0K | — |
| Change in accounts receivable | -$3.7M | $242.0K | $1.8M | $1.9M | -$2.9M | $667.0K | -$1.4M | $5.0M |
| Change in inventory | — | — | — | — | — | — | — | — |
| Change in accounts payable | — | — | -$3.0M | — | — | — | $4.8M | — |
| Purchases of investments | $44.3M | $83.2M | $16.8M | $81.7M | $128.9M | $191.2M | $0 | $0 |
| Sales/maturities of investments | $58.0M | $108.2M | $85.9M | $8.6M | $65.0M | $0 | $0 | $0 |
| Other investing activities | $0 | -$48.0K | $461.0K | -$249.0K | -$142.0K | -$120.0K | $0 | -$347.0K |
| Share repurchases | — | — | — | — | — | — | — | — |
| Tax withholding on stock comp | — | — | $0 | — | — | — | $0 | — |
| Other financing activities | — | — | — | $0 | — | — | — | -$4.0K |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $170.2M | $227.0M | $251.5M | $477.7M | $313.8M |
| Operating income | -$315.3M | -$559.8M | -$864.4M | -$2.21B | -$1.83B |
| Net income | -$312.8M | -$547.0M | -$892.9M | -$2.10B | -$1.83B |
| EPS (diluted) | $-5.64 | $-10.54 | $-18.37 | $-50.20 | $-1.39 |
| EPS (basic) | $-5.64 | $-10.54 | $-18.37 | $-50.15 | $-1.35 |
| Operating margin | -$185 | -$247 | -$344 | -$462 | -$583 |
| Net margin | -$184 | -$241 | -$355 | -$441 | -$583 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $1.12B | $1.38B | $1.67B | $2.54B | $2.07B |
| Total liabilities | $611.1M | $661.4M | $568.2M | $803.0M | $503.6M |
| Stockholders' equity | $508.6M | $716.1M | $1.10B | $1.74B | $1.51B |
| Total current assets | $471.8M | $602.7M | $1.00B | $1.45B | $1.72B |
| Total current liabilities | $96.0M | $107.3M | $163.9M | $173.0M | $134.8M |
| Cash & equivalents | $167.2M | $561.6M | $944.1M | $1.32B | $1.55B |
| Marketable securities (current) | $255.4M | $0 | — | — | — |
| Accounts receivable | $24.0M | $21.9M | $17.2M | $80.9M | $131.5M |
| Inventory | — | — | $46.0K | $4.4M | $3.4M |
| Other current assets | — | — | $362.0K | $487.0K | $698.0K |
| Property, plant & equipment | $167.8M | $203.7M | $188.2M | $314.8M | $145.8M |
| Goodwill | — | $0 | $49.2M | $60.2M | $21.3M |
| Intangible assets | $56.9M | $72.5M | $82.7M | $111.0M | $21.6M |
| Other non-current assets | $47.2M | $55.3M | $58.1M | $88.7M | $44.0M |
| Accounts payable | $10.6M | $14.2M | $9.3M | $10.5M | $8.2M |
| Accrued liabilities | — | — | — | $114.7M | $93.3M |
| Deferred revenue (current) | $18.9M | $27.7M | $44.5M | $47.8M | — |
| Other non-current liabilities | $22.9M | $16.6M | $24.4M | $31.2M | $36.0M |
| Common stock & paid-in capital | $6.0K | $5.0K | $5.0K | $190.0K | $161.0K |
| Retained earnings | -$6.15B | -$5.84B | -$5.29B | -$4.40B | -$2.30B |
| Accumulated other comprehensive income (loss) | $1.9M | -$1.8M | $1.5M | -$2.6M | -$1.7M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$171.1M | -$319.6M | -$295.5M | -$252.2M | -$253.8M |
| Investing cash flow | -$240.3M | -$62.2M | -$80.7M | -$67.4M | -$73.3M |
| Financing cash flow | $17.8M | -$1.7M | -$3.2M | $95.3M | $1.53B |
| Free cash flow | -$178.7M | -$382.1M | -$336.3M | -$304.5M | -$310.3M |
| Capital expenditures | $7.7M | $62.5M | $40.8M | $52.3M | $56.5M |
| Share-based compensation | $81.5M | $112.3M | $229.9M | $1.93B | $1.61B |
| Deferred income taxes | -$1.4M | -$936.0K | -$801.0K | -$14.6M | $0 |
| Change in accounts receivable | $1.5M | $4.7M | -$50.1M | -$55.0M | $114.1M |
| Change in inventory | — | — | — | -$164.0K | $626.0K |
| Change in accounts payable | -$3.0M | $4.8M | -$1.2M | -$10.8M | -$2.2M |
| Purchases of investments | $418.6M | $0 | $0 | — | — |
| Sales/maturities of investments | $159.5M | $0 | $0 | — | — |
| Other investing activities | -$50.0K | -$538.0K | $990.0K | $439.0K | $0 |
| Share repurchases | — | — | — | — | — |
| Tax withholding on stock comp | $0 | $0 | $23.0K | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding DNA as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Source: Business Quant SEC Form 13F · report period 2026-06-30 · 30 filers
Held by These Filers48.4%
Shares Outstanding63,711,102
| Filer | Shares | Value | % Out | Qtr Change | Filed |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4,282,903 | $42.4M | 6.72% | +17.6% | 2026-08-07 |
| VIKING GLOBAL INVESTORS LP | 3,577,128 | $35.4M | 5.61% | +0.0% | 2026-08-14 |
| Erste Asset Management GmbH | 2,536,939 | $25.9M | 3.98% | +30.3% | 2026-07-24 |
| BAILLIE GIFFORD & CO | 2,391,649 | $23.7M | 3.75% | +0.0% | 2026-08-06 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,087,293 | $20.7M | 3.28% | +9.0% | 2026-06-30 |
| Anchorage Capital Group, L.L.C. | 1,746,363 | $17.3M | 2.74% | +0.0% | 2026-08-14 |
| Legal & General Group Plc | 1,669,419 | $16.5M | 2.62% | +0.5% | 2026-08-14 |
| State Street Corp | 1,472,370 | $14.6M | 2.31% | +9.3% | 2026-08-07 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,222,016 | $12.1M | 1.92% | +21.1% | 2026-08-12 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 937,803 | $9.3M | 1.47% | +65.8% | 2026-06-30 |
| Allianz Asset Management GmbH | 785,798 | $7.8M | 1.23% | +12.2% | 2026-08-11 |
| UBS Group AG | 691,659 | $6.9M | 1.09% | +18.7% | 2026-08-13 |
| MILLENNIUM MANAGEMENT LLC | 638,676 | $6.3M | 1.00% | +30.9% | 2026-08-14 |
| AQR CAPITAL MANAGEMENT LLC | 621,625 | $6.2M | 0.98% | +110.9% | 2026-08-14 |
| SB INVESTMENT ADVISERS (UK) LTD | 610,729 | $6.1M | 0.96% | +0.0% | 2026-08-14 |
| Goldman Sachs Group Inc | 607,376 | $6.0M | 0.95% | -34.7% | 2026-08-14 |
| Bank Of America Corp /De/ | 545,852 | $5.4M | 0.86% | +14.5% | 2026-08-14 |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 541,845 | $5.4M | 0.85% | +0.0% | 2026-08-06 |
| RENAISSANCE TECHNOLOGIES LLC | 539,856 | $5.3M | 0.85% | +437.4% | 2026-08-13 |
| Northern Trust Corp | 405,141 | $4.0M | 0.64% | +21.2% | 2026-08-12 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 394,607 | $3.9M | 0.62% | +18.7% | 2026-08-14 |
| EXCHANGE TRADED CONCEPTS, LLC | 358,783 | $3.6M | 0.56% | +11.4% | 2026-07-22 |
| DIMENSIONAL FUND ADVISORS LP | 351,200 | $3.5M | 0.55% | +176.4% | 2026-08-11 |
| TUDOR INVESTMENT CORP ET AL | 335,710 | $3.3M | 0.53% | -27.8% | 2026-08-14 |
| VANGUARD FIDUCIARY TRUST CO | 312,573 | $3.1M | 0.49% | +13.8% | 2026-06-30 |
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-01-16 to 2026-10-19
Recent transactions
- Insiders have net sold 137,584 shares over the last 182 days, across 0 purchases and 11 sales.
- Most recent: Coen Steven P. (See remarks) — Open market sale of 766 shares on 2026-10-19.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)137,584 sh(11 txns)
Net Shares-137,584
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Coen Steven P. | See remarks | Open market sale | 2026-10-19 | 766 |
| Canton Barry | 10% owner | Open market sale | 2026-10-19 | 18,803 |
| Shetty Reshma P. | See remarks | Open market sale | 2026-10-19 | 22,369 |
| Kelly Jason R | See remarks | Open market sale | 2026-10-19 | 45,682 |
| HENRY CHRISTIAN O | Director | Open market sale | 2026-09-15 | 5,000 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-19 | Coen Steven P. | See remarks | Open market sale | 766 | $10.14 |
| 2026-10-19 | Canton Barry | 10% owner | Open market sale | 18,803 | $10.14 |
| 2026-10-19 | Canton Barry | 10% owner | Open market sale | 22,369 | $10.14 |
| 2026-10-19 | Shetty Reshma P. | See remarks | Open market sale | 22,369 | $10.14 |
| 2026-10-19 | Shetty Reshma P. | See remarks | Open market sale | 18,803 | $10.14 |
| 2026-10-19 | Kelly Jason R | See remarks | Open market sale | 45,682 | $10.14 |
| 2026-10-16 | Coen Steven P. | See remarks | Option exercise | 1,174 | — |
| 2026-10-16 | Coen Steven P. | See remarks | Option exercise | 312 | — |
| 2026-10-16 | Canton Barry | 10% owner | Option exercise | 26,802 | — |
| 2026-10-16 | Canton Barry | 10% owner | Option exercise | 9,762 | — |
| 2026-10-16 | Canton Barry | 10% owner | Option exercise | 29,279 | — |
| 2026-10-16 | Canton Barry | 10% owner | Option exercise | 10,619 | — |
| 2026-10-16 | Shetty Reshma P. | See remarks | Option exercise | 29,279 | — |
| 2026-10-16 | Shetty Reshma P. | See remarks | Option exercise | 10,619 | — |
| 2026-10-16 | Shetty Reshma P. | See remarks | Option exercise | 26,802 | — |
| 2026-10-16 | Shetty Reshma P. | See remarks | Option exercise | 9,762 | — |
| 2026-10-16 | Kelly Jason R | See remarks | Option exercise | 55,694 | — |
| 2026-10-16 | Kelly Jason R | See remarks | Option exercise | 25,790 | — |
| 2026-10-05 | Coen Steven P. | See remarks | Open market sale | 2,403 | $15.00 |
| 2026-09-15 | HENRY CHRISTIAN O | Director | Open market sale | 5,000 | $7.08 |
| 2026-08-24 | Coen Steven P. | See remarks | Open market sale | 330 | $6.98 |
| 2026-08-21 | Coen Steven P. | See remarks | Option exercise | 587 | — |
| 2026-08-21 | Coen Steven P. | See remarks | Option exercise | 156 | — |
| 2026-07-17 | Coen Steven P. | See remarks | Open market sale | 752 | $7.90 |
| 2026-07-16 | Coen Steven P. | See remarks | Option exercise | 1,174 | — |
| 2026-07-16 | Coen Steven P. | See remarks | Option exercise | 312 | — |
| 2026-05-22 | Coen Steven P. | See remarks | Open market sale | 307 | $8.33 |
| 2026-05-21 | Coen Steven P. | See remarks | Option exercise | 587 | — |
| 2026-05-21 | Coen Steven P. | See remarks | Option exercise | 156 | — |
| 2026-04-17 | Coen Steven P. | See remarks | Open market sale | 324 | $7.95 |
| 2026-04-16 | Coen Steven P. | See remarks | Option exercise | 587 | — |
| 2026-04-16 | Coen Steven P. | See remarks | Option exercise | 156 | — |
| 2026-04-13 | Coen Steven P. | See remarks | Open market sale | 33,171 | $6.41 |
| 2026-04-10 | Coen Steven P. | See remarks | Option exercise | 28,368 | — |
| 2026-04-10 | Coen Steven P. | See remarks | Option exercise | 45,553 | — |
| 2026-04-10 | Canton Barry | 10% owner | Open market sale | 124,727 | $6.43 |
| 2026-04-10 | Shetty Reshma P. | See remarks | Open market sale | 124,727 | $6.43 |
| 2026-04-09 | Canton Barry | 10% owner | Option exercise | 251,786 | — |
| 2026-04-09 | Shetty Reshma P. | See remarks | Option exercise | 251,786 | — |
| 2026-04-09 | Shetty Reshma P. | See remarks | Open market sale | 13,116 | $6.40 |
| 2026-04-09 | Canton Barry | 10% owner | Open market sale | 13,116 | $6.40 |
| 2026-04-09 | Kelly Jason R | See remarks | Open market sale | 109,767 | $6.40 |
| 2026-04-08 | Shetty Reshma P. | See remarks | Option exercise | 27,738 | — |
| 2026-04-08 | Shetty Reshma P. | See remarks | Open market sale | 13,155 | $6.93 |
| 2026-04-08 | Canton Barry | 10% owner | Option exercise | 27,738 | — |
| 2026-04-08 | Canton Barry | 10% owner | Open market sale | 13,155 | $6.93 |
| 2026-04-08 | Kelly Jason R | See remarks | Option exercise | 212,949 | — |
| 2026-04-08 | Kelly Jason R | See remarks | Open market sale | 97,015 | $6.93 |
| 2026-04-07 | Shetty Reshma P. | See remarks | Option exercise | 27,738 | — |
| 2026-04-07 | Canton Barry | 10% owner | Option exercise | 27,738 | — |
| 2026-04-07 | Kelly Jason R | See remarks | Option exercise | 212,949 | — |
| 2026-03-16 | Coen Steven P. | See remarks | Open market sale | 708 | $6.74 |
| 2026-03-13 | Coen Steven P. | See remarks | Option exercise | 1,174 | — |
| 2026-03-13 | Coen Steven P. | See remarks | Option exercise | 312 | — |
| 2026-01-20 | Coen Steven P. | See remarks | Open market sale | 972 | $8.92 |
| 2026-01-16 | Coen Steven P. | See remarks | Option exercise | 587 | — |
| 2026-01-16 | Coen Steven P. | See remarks | Option exercise | 156 | — |
| 2026-01-16 | Coen Steven P. | See remarks | Option exercise | 1,062 | — |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-11-02 16:14 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-29 | 8-K | 2026-10-29 | View on SEC.gov → |
| 2026-10-21 | 4 | 2026-10-16 | View on SEC.gov → |
| 2026-10-21 | 4 | 2026-10-16 | View on SEC.gov → |
| 2026-10-21 | 4 | 2026-10-16 | View on SEC.gov → |
| 2026-10-21 | 4 | 2026-10-16 | View on SEC.gov → |
| 2026-10-07 | 4 | 2026-10-05 | View on SEC.gov → |
| 2026-09-16 | 4 | 2026-09-15 | View on SEC.gov → |
| 2026-08-25 | 4 | 2026-08-21 | View on SEC.gov → |
| 2026-08-06 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-05 | 8-K | 2026-08-05 | View on SEC.gov → |
| 2026-07-30 | 4 | 2026-07-28 | View on SEC.gov → |
| 2026-07-30 | 4 | 2026-07-28 | View on SEC.gov → |
Recent news
Headlines about DNA (Ginkgo Bioworks Holdings, Inc.). Links open the publisher — we don’t host full articles.
-
FDA Grants Accelerated Approval to Inovio DNA Immunotherapy for RRP
BioPharm International · 2026-11-02 -
FDA Approves First Plasmid DNA-Based Immunotherapy for Adults With RRP
The American Journal of Managed Care · 2026-11-02 -
FDA Approves Inovio’s Plasma DNA-Based Immunotherapy for Recurrent Respiratory Papillomatosis
GenomeWeb · 2026-11-02 -
Nancy Guthrie Case Latest Update Today: Savannah Guthrie Shares Emotional Message, Family Renews Plea for Help; FBI Investigates DNA Evidence in Florida
The Sunday Guardian · 2026-11-02 -
Can Ginkgo Bioworks (NYSE:DNA) Cut Cash Burn After Its Revenue Reset?
Kalkine Media · 2026-11-02 -
Inovio stock rises 2.5-fold on plasmid DNA drug approval
pharmaphorum · 2026-11-02 -
NeoSoul Price (DNA/USD) Today | Live Price, Market Cap & Chart
Binance · 2026-11-01 -
Nancy Guthrie Case Latest Update Today: Sheriff Chris Nanos Shares ‘New DNA Testing’ Update After Florida Lab Meetings; Check What Investigators Revealed
The Sunday Guardian · 2026-11-01
No headlines in this category right now — try “All”.